The name change and office relocation are routine corporate actions with no expected impact on operations or stock performance. Monitor for any future business development announcements under the new name.
OLMA drugs
OLMA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $7.56entry
- T+1 · 20h ago −2.65%α −0.73% · $7.36
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Olema Pharmaceuticals, Inc. changed its corporate name to Olema Oncology, Inc. via an Eighth Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State, effective November 12, 2026. The company also amended its bylaws to reflect the new name and relocated its principal executive offices from San Francisco to South San Francisco. The common stock continues trading under the same ticker symbol OLMA on Nasdaq.
Key Facts
- Corporate name changed from Olema Pharmaceuticals, Inc. to Olema Oncology, Inc. effective November 12, 2026.
- Eighth Amended and Restated Certificate of Incorporation filed with Delaware Secretary of State.
- Bylaws amended and restated to reflect the name change.
- Principal executive offices relocated from 780 Brannan Street, San Francisco, CA to 365 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080.
- Common stock continues trading on Nasdaq Global Select Market under ticker OLMA.
- Stockholder approval was not required for the name change under Delaware law.
Financial Impact
No financial impact; name change and office relocation are administrative in nature.
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-458572 |
| Document: olma-ex3_1.htm | 0001193125-26-458572 |
| Document: olma-20261112.htm | 0001193125-26-458572 |
| Document: olma-ex99_1.htm | 0001193125-26-458572 |
| Document: 0001193125-26-458572-index-headers.html | 0001193125-26-458572 |
| Document: 0001193125-26-458572-index.html | 0001193125-26-458572 |
| Document: 0001193125-26-458572.txt | 0001193125-26-458572 |
Track record
20 reports on OLMA
1 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +38.44% at T+60 after the Aug 9, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.29 Now $7.36 +0.96% settles Feb 12
- Nov 12, 20264d ago 8-K Neutral 2/10 Viewing Entry $7.56 Now $7.36 −2.65% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $7.27 Now $7.36 +1.24% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $7.33 Now $7.36 +0.41% settles Feb 4
- Oct 16, 20264w ago SC 13D/A Neutral 2/10 Entry $7.11 Now $7.36 +3.52% settles Jan 14
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $6.58 Now $7.36 +11.85% settles Jan 13
- Oct 2, 20266w ago Press Release Neutral 2/10 Entry $8.25 Now $7.36 −10.79% settles Dec 30
- Aug 10, 202614w ago 8-K Neutral 5/10 No price data
- Aug 10, 202614w ago Press Release Neutral 4/10 Entry $10.43 to $7.54 Now $7.36 −29.43% ▼ −27.71% −27.22% vs SPY
- Aug 9, 202614w ago Institutional Cluster Bearish 6/10 Entry $11.94 to $7.35 Now $7.36 +38.36% ▲ +38.44% +36.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers